Arbutus Biopharma Corp: Form 8-K, filed Feb 14, 2018
Filed with the SEC on Feb 14, 2018 and accepted by EDGAR at Feb 14, 2018, 14:40 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001171843-18-001133. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.